We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$439M
AUM Growth
+$22.7M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
18.86%
Holding
332
New
121
Increased
28
Reduced
53
Closed
100

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.29M
2
AXP icon
American Express
AXP
+$7.22M
3
CVS icon
CVS Health
CVS
+$4.98M
4
DVN icon
Devon Energy
DVN
+$4.92M
5
AMP icon
Ameriprise Financial
AMP
+$4.87M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$8.18M
2
CB icon
Chubb
CB
+$7.62M
3
NSC icon
Norfolk Southern
NSC
+$7.16M
4
PSA icon
Public Storage
PSA
+$7.08M
5
CPB icon
Campbell Soup
CPB
+$6.99M

Sector Composition

Rank Sector Weight
1 Technology 16.64%
2 Financials 14.44%
3 Healthcare 13.99%
4 Industrials 11.57%
5 Energy 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PENN icon
176
PENN Entertainment
PENN
$2.7B
$160K 0.04%
+13,165
New +$156K
STRL icon
177
Sterling Infrastructure
STRL
$16.7B
$160K 0.04%
+17,100
New +$146K
OSIR
178
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$160K 0.04%
10,275
AP icon
179
Ampco-Pittsburgh
AP
$193M
$156K 0.04%
+6,821
New +$144K
MGIC
180
DELISTED
Magic Software Enterprises
MGIC
$156K 0.04%
+20,790
New +$166K
LSAK icon
181
Lesaka Technologies
LSAK
$420M
$155K 0.04%
+13,660
New +$141K
PACD
182
DELISTED
Pacific Drilling S A
PACD
$149K 0.03%
1,486
RESI
183
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$148K 0.03%
5,680
-12,530
-69% -$347K
WEB
184
DELISTED
Web.com Group, Inc.
WEB
$135K 0.03%
+4,680
New +$154K
TECK icon
185
Teck Resources
TECK
$32.6B
$123K 0.03%
+5,390
New +$121K
BGS icon
186
B&G Foods
BGS
$286M
$120K 0.03%
+3,660
New +$120K
AGU
187
DELISTED
Agrium
AGU
$116K 0.03%
+1,265
New +$117K
CLF icon
188
Cleveland-Cliffs
CLF
$6.99B
$109K 0.02%
7,275
-105,000
-94% -$1.78M
EGAS
189
DELISTED
Gas Natural Inc.
EGAS
$104K 0.02%
+9,910
New +$104K
REX icon
190
REX American Resources
REX
$1.41B
$94K 0.02%
+7,680
New +$84.5K
BRC icon
191
Brady Corp
BRC
$4.57B
$93K 0.02%
3,120
REN
192
DELISTED
Resolute Energy Corporaton
REN
$89K 0.02%
+2,049
New +$80.9K
SMA
193
DELISTED
SYMMETRY MEDICAL INC
SMA
$88K 0.02%
+9,970
New +$86.9K
OSUR icon
194
OraSure Technologies
OSUR
$279M
$87K 0.02%
+10,070
New +$70.6K
CCC
195
DELISTED
Calgon Carbon Corp
CCC
$87K 0.02%
+3,910
New +$83.3K
ACCO icon
196
Acco Brands
ACCO
$407M
$85K 0.02%
13,250
JBSS icon
197
John B. Sanfilippo & Son
JBSS
$972M
$84K 0.02%
3,160
-7,795
-71% -$194K
STJ
198
DELISTED
St Jude Medical
STJ
$79K 0.02%
1,140
-2,880
-72% -$187K
THRM icon
199
Gentherm
THRM
$1.27B
$74K 0.02%
+1,670
New +$65.7K
RTN
200
DELISTED
Raytheon Company
RTN
$73K 0.02%
795

Similar funds

C.M. Bidwell & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, C.M. Bidwell & Associates held 332 positions worth $439M, up 5.5% from $416M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

C.M. Bidwell & Associates's Q2 2014 filing shows 121 new, 28 increased, 53 reduced and 100 closed positions. Its largest new stake was Gilead Sciences: 93,610 shares worth $7.76M. The largest sale was Charles Schwab, an estimated $8.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2014 buy was Gilead Sciences: 93,610 shares worth $7.76M.
  • C.M. Bidwell & Associates added most to CVS Health in Q2 2014, an estimated $4.98M increase.
  • C.M. Bidwell & Associates's biggest Q2 2014 reduction was Chubb, cutting an estimated $7.62M.
  • C.M. Bidwell & Associates fully exited Charles Schwab in Q2 2014, selling an estimated $8.18M.
  • C.M. Bidwell & Associates's ten largest holdings make up 19% of its $439M portfolio in Q2 2014.
  • C.M. Bidwell & Associates opened 121 new positions and closed 100 in Q2 2014.
  • C.M. Bidwell & Associates's portfolio value rose 5.5% quarter-over-quarter to $439M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2014, filed 12 Aug 2014.